Daniel Regan

2013

In 2013, Daniel Regan earned a total compensation of $4.5M as Former Chief Commercial Officer at Intercept Pharmaceuticals.

Compensation breakdown

Bonus$167,708
Option Awards$3,980,227
Salary$277,083
Other$36,147
Total$4,461,165

Regan received $4M in option awards, accounting for 89% of the total pay in 2013.

Regan also received $167.7K in bonus, $277.1K in salary and $36.1K in other compensation.

Rankings

In 2013, Daniel Regan's compensation ranked 1,486th out of 12,286 executives tracked by ExecPay. In other words, Regan earned more than 87.9% of executives.

ClassificationRankingPercentile
All
1,486
out of 12,286
88th
Division
Manufacturing
483
out of 4,612
90th
Major group
Chemicals And Allied Products
129
out of 1,462
91st
Industry group
Drugs
87
out of 1,156
93rd
Industry
Pharmaceutical Preparations
77
out of 890
91st
Source: SEC filing on June 20, 2016.

Regan's colleagues

We found three more compensation records of executives who worked with Daniel Regan at Intercept Pharmaceuticals in 2013.

2013

Mark Pruzanski

Intercept Pharmaceuticals

Chief Executive Officer

2013

David Shapiro

Intercept Pharmaceuticals

Chief Medical Officer

2013

Barbara Duncan

Intercept Pharmaceuticals

Chief Financial Officer

In-depth

You may also like